«
»

DrDental, Study reveals target for drug development for TMJD
07/24/14 9:00 AM

According to a study in mice, researchers at Duke Medicine identified a protein that is critical to TMJD (Temporomandibular joint disorder) pain, and could be a promising target for developing treatments for the disorder. Their findings are published in the August issue of the journal PAIN®.

 

Related posts:

  1. Study Assesses Mood Disorders With TMJ Pain
  2. DrDental, Tooth Development and Weaning, What Chimpanzees Can Teach Us
  3. Simple saliva test may reveal deadly diseases early enough to treat them
Posted by DrDental | in Individual Dental Plans | No Comments »
Leave a Reply

You must be logged in to post a comment.

 

DRDENTAL.COM DISCLOSURES: This is not an attempt to describe the product coverage and its' contents but merely used as a sales tool for the purpose of product illustration. The website and its' owners cannot make recommendations as to whether any illustrated product may meet the users' particular needs. Therefore, the suitability of the product is the final determination of the user of this website. The use of this website is acceptance of the sites' privacy statement. Coverage is not in effect until an application is signed, transmitted, payment received and approved by the underwriting company unless otherwise specifically stated. A physical and/or background inspection may be done to verify the information provided. The quote(s) will be based up on the underwriting information you supplied and the quote(s) is/are subject to change upon inspection and review by the underwriting company. The underwriting company reserves the right to determine the final coverage, premium and acceptability  If you have any questions regarding the information collected, please contact the agency. All quotes are provided by DEL AMO Insurance Services, Inc,. DBA:  InsComp Insurance Services and/or one of it's affiliated agents, brokers, agencies, brokerages, and/or companies  Lic: 0B93601  Agent David Blunt, Lic: 0638553. Commercial use by others is prohibited by law. No portion of any news or information from this website may be photocopied, faxed, mailed, distributed, transmitted, published, broadcasted, duplicated, or re-distributed in any manner for any purpose without prior written authorization of its' owner.